Metraipolis › archive › dc_0232bf78f60d

Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer — Europe PMC PMID:41716796

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716796
DOI
10.3389/fmed.2026.1730818
License (as archived)
solo-consultazione
Archived
2026-11-06T03:14:00.995Z
SHA-256 of the archived text
0fbe57e0bb15c39393edd3e008a5f5142fa4de221e8b12d37550b6add97dfc39
Stable URL of this page
https://metraipolis.com/documento/dc_0232bf78f60d

How to cite

Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer — Europe PMC PMID:41716796 — Europe PMC (en), https://europepmc.org/article/MED/41716796 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0232bf78f60d (Metraipolis archive dc_0232bf78f60d, sha256 0fbe57e0bb15c39393edd3e008a5f5142fa4de221e8b12d37550b6add97dfc39)
BibTeX
@misc{dc0232bf78f60d,
  title = {Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer — Europe PMC PMID:41716796},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716796},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0232bf78f60d; sha256 0fbe57e0bb15c39393edd3e008a5f5142fa4de221e8b12d37550b6add97dfc39},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716796. Agents can read the archived copy with the MCP tool read_document.